Skip to Main Content

Paper Details

Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia.
Sci Transl Med
11
2022
Author NameAffiliation
Guoqing DuDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital
Ching-Hon PuiSt. Jude Children's Research Hospital
  • 1 - 2

Datasets

Release 1.2